These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 82772)

  • 41. Zinc-copper interaction provides a novel and apparently effective alternative therapy for Wilson's disease.
    Sandstead HH
    J Lab Clin Med; 1987 May; 109(5):521-2. PubMed ID: 3572198
    [No Abstract]   [Full Text] [Related]  

  • 42. Abnormalities of the physiology of copper in Wilson's disease. II. The internal kinetics of copper.
    O'Reilly S; Pollycove M; Tono M; Herradora L
    Arch Neurol; 1971 Jun; 24(6):481-8. PubMed ID: 5089893
    [No Abstract]   [Full Text] [Related]  

  • 43. Oral zinc sulphate treatment in Wilson's disease.
    Pasqualicchio M; Marrella M; Moretti U; Velo GP; Deganello A; Tomelleri G; Milanino R
    Acta Physiol Hung; 1990; 75 Suppl():233-4. PubMed ID: 2371874
    [No Abstract]   [Full Text] [Related]  

  • 44. Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate.
    Dzieżyc K; Litwin T; Sobańska A; Członkowska A
    Neurol Neurochir Pol; 2014; 48(3):214-8. PubMed ID: 24981187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wilson's disease presenting as haemolytic anaemia and its successful treatment with penicillamine and zinc.
    Kong HL; Yap IL; Kueh YK
    Singapore Med J; 1996 Dec; 37(6):670-2. PubMed ID: 9104075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model.
    Lee DY; Brewer GJ; Wang YX
    J Lab Clin Med; 1989 Dec; 114(6):639-45. PubMed ID: 2592854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful long term oral zinc in florid Wilson's disease: a case report.
    Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
    Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zinc treatment of Wilson's disease.
    Brewer GJ; Hill GM; Prasad AS; Rabbani P
    Ann Intern Med; 1984 Jul; 101(1):144-5. PubMed ID: 6732083
    [No Abstract]   [Full Text] [Related]  

  • 49. Zinc as a treatment for Wilson's disease--an orphan among orphans.
    Brewer GJ; Hill GM
    Prog Clin Biol Res; 1985; 197():143-56. PubMed ID: 4070288
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical considerations for an effective medical therapy in Wilson's disease.
    Weiss KH; Stremmel W
    Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Wilson's disease: an update, with emphasis on new approaches to treatment.
    Brewer GJ; Yuzbasiyan-Gurkan V
    Dig Dis; 1989; 7(4):178-93. PubMed ID: 2663256
    [No Abstract]   [Full Text] [Related]  

  • 53. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 55. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H
    Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract]   [Full Text] [Related]  

  • 56. [Variations in the composition of breast milk in Wilson's disease].
    Bunke H; Cario WR; Schneider M
    Kinderarztl Prax; 1989 Feb; 57(2):89-92. PubMed ID: 2724779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease.
    Osborn SB; Szaz KF; Walshe JM
    Q J Med; 1969 Oct; 38(152):467-74. PubMed ID: 5355538
    [No Abstract]   [Full Text] [Related]  

  • 58. Non-invasive quantitation of corneal copper in hepatolenticular degeneration (Wilson's disease).
    Belkin M; Zeimer R; Chajek T; Friedman G; Melamed E
    Lancet; 1976 Feb; 1(7956):391-2. PubMed ID: 55651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreaticobiliary secretion of zinc and copper in normal persons and patients with Wilson's disease.
    Lee HH; Hill GM; Sikha VK; Brewer GJ; Prasad AS; Owyang C
    J Lab Clin Med; 1990 Sep; 116(3):283-8. PubMed ID: 2401845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Copper deficiency in Wilson's disease: an avoidable complication of treatment.
    da Silva-Júnior FP; Lucato LT; Machado AA; Barbosa ER
    Mov Disord; 2011 Nov; 26(13):2448-9; author reply 2449-50. PubMed ID: 21956703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.